Consider Switching Some VTE Patients to a Low-Dose Direct Oral Anticoagulant

More patients will use LOW-dose direct oral anticoagulants (DOACs) long-term to prevent recurrent venous thromboembolism (VTE).

We're used to giving warfarin or a DOAC (Eliquis, etc) for 3 months for patients who have a VTE due to a short-term risk such as surgery or minor trauma.

And we know to use long-term anticoagulation to prevent a VTE recurrence for most patients at high risk...such as those with active cancer or a clotting disorder.